Mario Boccadoro
Mario Boccadoro
Professor of Hematology, University of Torino, Italy
Verified email at unito.it
TitleCited byYear
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson, P Sonneveld, MW Schuster, D Irwin, EA Stadtmauer, ...
New England journal of medicine 352 (24), 2487-2498, 2005
25742005
International staging system for multiple myeloma
PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ...
Journal of clinical oncology 23 (15), 3412-3420, 2005
23362005
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
International Myeloma Working Group
British journal of haematology 121 (5), 749-757, 2003
18282003
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
9052006
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414, 2008
7232008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hajek, ...
Leukemia 23 (2), 215, 2009
6752009
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149, 2012
5862012
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
F Pichiorri, SS Suh, M Ladetto, M Kuehl, T Palumbo, D Drandi, C Taccioli, ...
Proceedings of the National Academy of Sciences 105 (35), 12885-12890, 2008
5822008
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial
PG Richardson, P Sonneveld, M Schuster, D Irwin, E Stadtmauer, T Facon, ...
Blood 110 (10), 3557-3560, 2007
5682007
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and …
RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ...
Leukemia 24 (6), 1121, 2010
5602010
A comparison of allografting with autografting for newly diagnosed myeloma
B Bruno, M Rotta, F Patriarca, N Mordini, B Allione, F Carnevale-Schianca, ...
New England Journal of Medicine 356 (11), 1110-1120, 2007
5292007
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
BGM Durie, RA Kyle, A Belch, W Bensinger, J Blade, M Boccadoro, ...
The Hematology Journal 4 (6), 379-398, 2003
4902003
Autologous transplantation and maintenance therapy in multiple myeloma
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
4072014
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple …
A Palumbo, S Bringhen, D Rossi, M Cavalli, A Larocca, R Ria, M Offidani, ...
Journal of Clinical Oncology 28 (34), 5101-5109, 2010
4022010
Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy
F Mandelli, G Avvisati, S Amadori, M Boccadoro, A Gernone, VM Lauta, ...
New England Journal of Medicine 322 (20), 1430-1434, 1990
3991990
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
A Palumbo, S Bringhen, AM Liberati, T Caravita, A Falcone, V Callea, ...
Blood 112 (8), 3107-3114, 2008
3942008
C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system
R Bataille, M Boccadoro, B Klein, B Durie, A Pileri
Blood 80 (3), 733-737, 1992
3741992
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The Lancet Oncology 17 (8), e328-e346, 2016
3632016
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
S Iida, PH Rao, M Butler, P Corradini, M Boccadoro, B Klein, ...
Nature genetics 17 (2), 226, 1997
3611997
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
S Bringhen, A Larocca, D Rossi, M Cavalli, M Genuardi, R Ria, S Gentili, ...
Blood 116 (23), 4745-4753, 2010
3552010
The system can't perform the operation now. Try again later.
Articles 1–20